Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.41 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.41 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.41 |
| ▸ | AHR | P35869 | 5/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.35 |
| ▸ | NMT1 | P30419 | 1/20 | 0.35 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.34 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.33 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.33 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.33 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.33 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.33 |
| ▸ | ERN1 | O75460 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30007490 | 0.84 | TSHR (0.41) | TDP1CYP3A4TSHRGABRA1GABRB1 | |
| SCHEMBL23327014 | 0.84 | TSHR (0.41) | TDP1CYP3A4TSHRGABRA1GABRB1 | |
| SCHEMBL31619139 | 0.80 | CYP3A4 (0.38) | TDP1CYP3A4TSHRGABRA1GABRB1 | |
| SCHEMBL3208926 | 0.80 | CYP3A4 (0.38) | TDP1CYP3A4TSHRGABRA1GABRB1 | |
| SCHEMBL13550070 | 0.80 | CYP3A4 (0.40) | TDP1CYP3A4TSHRGABRA1GABRB1 | |
| SCHEMBL12849942 | 0.79 | TSHR (0.47) | CYP3A4TSHRAHRERN1ALDH1A1 | |
| SCHEMBL31076317 | 0.74 | GPR35 (0.36) | TDP1CYP3A4TSHRGABRA1GABRB1 | |
| SCHEMBL1494504 | 0.73 | GAA (0.35) | AHRKMT2ACA1CA9 | |
| SCHEMBL11310694 | 0.73 | HSD17B10 (0.50) | TDP1CYP3A4TSHRGABRA1GABRB1 | |
| SCHEMBL671786 | 0.73 | ALDH1A1 (0.39) | CYP3A4TSHRAHRALOX15GPR35 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250234703-A1 | Organic Compound And Organic Light-Emitting Element Comprising Same | P&H TECH CO., LTD (KR) | 2025-07-17 | — | — | US | disclosed |
| CN-117940412-A | Fluoranthene derivative, light-emitting element, and photoelectric conversion element | 东丽先端材料研究开发（中国）有限公司 | 2024-04-26 | — | — | CN | disclosed |
| WO-2023182754-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | (주)피엔에이치테크 | 2023-09-28 | — | — | WO | disclosed |
| WO-2023125801-A1 | FLUORANTHENE DERIVATIVE, LIGHT-EMITTING ELEMENT, AND PHOTOELECTRIC CONVERSION ELEMENT | 东丽先端材料研究开发（中国）有限公司 | 2023-07-06 | — | — | WO | disclosed |
| WO-2023125801-A1 | FLUORANTHENE DERIVATIVE, LIGHT-EMITTING ELEMENT, AND PHOTOELECTRIC CONVERSION ELEMENT | 东丽先端材料研究开发（中国）有限公司 | 2023-07-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250234703-A1 | Organic Compound And Organic Light-Emitting Element Comprising Same | CRY2, CRY1, RBP4 | TDP1 2470/4885CYP3A4 515/4885TSHR 4594/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.